Result of General Meeting

RNS Number : 3933W
Maven Income and Growth VCT 3 PLC
10 December 2019
 

 

 

Maven Income and Growth VCT 3 PLC (the Company)

 

Result of General Meeting - 10 December 2019 (General Meeting)

This Announcement is made by the Company in connection with the offer for subscription of new ordinary shares of 10p each in the capital of the Company ("Offer Shares").

The Board is pleased to announce that, at the General Meeting of the Company held on 10 December 2019, the resolutions proposed, as set out in the Notice of General Meeting in the Circular to Shareholders dated 13 November 2019, were duly passed on a show of hands as follows:

Resolution 1 - to authorise the Directors to allot Offer Shares; and

Resolution 2 - to authorise the disapplication of pre-emption rights.

At the record date for the General Meeting, being 6 December 2019, the total number of voting rights in the Company stood at 67,983,600 and the total number of ordinary shares in issue was 67,983,600. The Company advises that, for the General Meeting, valid proxy appointments were made in respect of 3,425,861 ordinary shares and that the number of proxy votes lodged for each Resolution were as follows:

 

Resolution

For

Discretion

Against

Withheld

Total

1

2,970,475

62,796

392,590

0

3,425,861

2

2,970,475

62,796

392,590

0

3,425,861

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions.

 

Passing of Resolutions

 

A copy of the Resolutions passed at the General Meeting held on 10 December 2019 has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

10 December 2019


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMLBLFFKLFLFBE
UK 100